Macrophages from alpha 7 nicotinic acetylcholine receptor knockout mice demonstrate increased cholesterol accumulation and decreased cellular paraoxonase expression: A possible link between the nervous system and atherosclerosis development

Biochemical and Biophysical Research Communications

Volumn 390, Issue 1, 2009, Pages 148-154

  Wilund, Kenneth R ^a   Rosenblat, Mira ^b   Chung, Hae Ryong ^a   Volkova, Nina ^b   Kaplan, Marielle ^b   Woods, Jeffrey A ^a   Aviram, Michael ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Alpha 7 nicotinic acetylcholine receptor; Atherosclerosis; Inflammation; Macrophages; Oxidative stress; Paraoxonase

Indexed keywords

APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; BUNGAROTOXIN RECEPTOR; C REACTIVE PROTEIN; CHOLESTEROL; INTERLEUKIN 6; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; C57BL 6 MOUSE; CHOLESTEROL BLOOD LEVEL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DISEASE COURSE; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CHOLESTEROL; INFLAMMATION; MACROPHAGES; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTORS, NICOTINIC;

MUS;

EID: 70349956474     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.088     Document Type: Article

References (24)

1. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., and Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (2003) 384-388
2. Tracey K.J. Reflex control of immunity. Nat. Rev. Immunol. 9 (2009) 418-428
3. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
4. Vela D., Buja L.M., Madjid M., Burke A., Naghavi M., Willerson J.T., Casscells S.W., and Litovsky S. The role of periadventitial fat in atherosclerosis. Arch. Pathol. Lab. Med. 131 (2007) 481-487
5. Amenta F., Cavallotti C., Ferrante F., and Zomparelli M. The cholinergic innervation of the aorta. Acta Histochem. 66 (1980) 197-203
6. Denn M.J., and Stone H.L. Autonomic innervation of dog coronary arteries. J. Appl. Physiol. 41 (1976) 30-35
7. Rosenblat M., and Aviram M. Paraoxonases role in the prevention of cardiovascular diseases. Biofactors 35 (2009) 98-104
8. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52 (1978) 302-310
9. Gaidukov L., and Tawfik D.S. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Biochemistry 44 (2005) 11843-11854
10. LeBel C.P., Ischiropoulos H., and Bondy S.C. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5 (1992) 227-231
11. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med. 30 (1983) 111-118
12. Bass D.A., Parce J.W., Dechatelet L.R., Szejda P., Seeds M.C., and Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130 (1983) 1910-1917
13. Aviram M., Rosenblat M., Etzioni A., and Levy R. Activation of NADPH oxidase required for macrophage-mediated oxidation of low-density lipoprotein. Metabolism 45 (1996) 1069-1079
14. Khersonsky O., and Tawfik D.S. Chromogenic and fluorogenic assays for the lactonase activity of serum paraoxonases. Chembiochem 7 (2006) 49-53
15. Daly J.W. Nicotinic agonists, antagonists, and modulators from natural sources. Cell. Mol. Neurobiol. 25 (2005) 513-552
16. Rosenblat M., Hayek T., Hussein K., and Aviram M. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 175-180
17. Fuhrman B., Judith O., Keidar S., Ben-Yaish L., Kaplan M., and Aviram M. Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radic. Biol. Med. 23 (1997) 34-46
18. Knight J.A. Review: free radicals, antioxidants, and the immune system. Ann. Clin. Lab. Sci. 30 (2000) 145-158
19. Shiner M., Fuhrman B., and Aviram M. A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity. Biochem. Biophys. Res. Commun. 349 (2006) 1094-1099
20. Wessler I., Kirkpatrick C.J., and Racke K. The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin. Exp. Pharmacol. Physiol. 26 (1999) 198-205
21. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II2-II10
22. Dong Q., and Wright J.R. Expression of C-reactive protein by alveolar macrophages. J. Immunol. 156 (1996) 4815-4820
23. Aviram M., and Rosenblat M. Oxidative stress in cardiovascular disease: role of oxidized lipoproteins in macrophage foam cell formation and atherosclerosis. In Redox-Genome Interactions in Health and Disease (2003), Dekker, New York 557-590
24. Sun B., Boyanovsky B.B., Connelly M.A., Shridas P., van der Westhuyzen D.R., and Webb N.R. Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J. Lipid Res. 48 (2007) 2560-2570